STAT3(Y705F)-TAL-Luc Citations (3)

Originally described in: The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent.
Dabir S, Kluge A, Dowlati A Mol Cancer Res. 2009 Nov;7(11):1854-60. doi: 10.1158/1541-7786.MCR-09-0313. Epub 2009 Nov 10. PubMed Journal

---

Articles Citing STAT3(Y705F)-TAL-Luc

Articles
Inhibition of glycogen synthase kinase 3 beta (GSK3beta) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity. Gao S, Li S, Duan X, Gu Z, Ma Z, Yuan X, Feng X, Wang H. Mol Carcinog. 2017 Jun 2. doi: 10.1002/mc.22685. PubMed
Dynamic monitoring of STAT3 activation in live cells using a novel STAT3 Phospho-BRET sensor. Dimri S, Arora R, Jasani A, De A. Am J Nucl Med Mol Imaging. 2019 Dec 15;9(6):321-334. eCollection 2019. PubMed
Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells. Ye M, Huang W, Liu R, Kong Y, Liu Y, Chen X, Xu J. Front Pharmacol. 2021 Jul 5;12:651516. doi: 10.3389/fphar.2021.651516. eCollection 2021. PubMed

If you have published an article using this material, please email us at to have your article added to this page.